vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Orange County Bancorp, Inc. (OBT). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $33.0M, roughly 1.4× Orange County Bancorp, Inc.). Orange County Bancorp, Inc. runs the higher net margin — 37.6% vs -19.9%, a 57.6% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 20.6%). Orange County Bancorp, Inc. produced more free cash flow last quarter ($41.3M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 14.3%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.
ABCL vs OBT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $33.0M |
| Net Profit | $-8.9M | $12.4M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 41.4% |
| Net Margin | -19.9% | 37.6% |
| Revenue YoY | 788.4% | 20.6% |
| Net Profit YoY | 73.9% | 73.5% |
| EPS (diluted) | $-0.03 | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $33.0M | ||
| Q3 25 | $9.0M | $33.7M | ||
| Q2 25 | $17.1M | $32.5M | ||
| Q1 25 | $4.2M | $28.0M | ||
| Q4 24 | $5.0M | $27.4M | ||
| Q3 24 | $6.5M | $27.1M | ||
| Q2 24 | $7.3M | $27.9M | ||
| Q1 24 | $10.0M | $25.3M |
| Q4 25 | $-8.9M | $12.4M | ||
| Q3 25 | $-57.1M | $10.0M | ||
| Q2 25 | $-34.7M | $10.5M | ||
| Q1 25 | $-45.6M | $8.7M | ||
| Q4 24 | — | $7.2M | ||
| Q3 24 | $-51.1M | $3.2M | ||
| Q2 24 | $-36.9M | $8.2M | ||
| Q1 24 | $-40.6M | $9.3M |
| Q4 25 | -63.7% | 41.4% | ||
| Q3 25 | -851.8% | 38.6% | ||
| Q2 25 | -290.2% | 41.9% | ||
| Q1 25 | -1479.6% | 40.3% | ||
| Q4 24 | — | 32.8% | ||
| Q3 24 | -1439.4% | 14.8% | ||
| Q2 24 | -1276.2% | 36.6% | ||
| Q1 24 | -551.5% | 45.9% |
| Q4 25 | -19.9% | 37.6% | ||
| Q3 25 | -637.8% | 29.7% | ||
| Q2 25 | -203.3% | 32.2% | ||
| Q1 25 | -1077.2% | 31.1% | ||
| Q4 24 | — | 26.2% | ||
| Q3 24 | -785.4% | 11.8% | ||
| Q2 24 | -504.3% | 29.4% | ||
| Q1 24 | -408.0% | 36.7% |
| Q4 25 | $-0.03 | $0.94 | ||
| Q3 25 | $-0.19 | $0.75 | ||
| Q2 25 | $-0.12 | $0.87 | ||
| Q1 25 | $-0.15 | $0.77 | ||
| Q4 24 | — | $0.64 | ||
| Q3 24 | $-0.17 | $0.28 | ||
| Q2 24 | $-0.13 | $0.73 | ||
| Q1 24 | $-0.14 | $0.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $284.4M |
| Total Assets | $1.4B | $2.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | — |
| Q4 25 | $966.9M | $284.4M | ||
| Q3 25 | $964.0M | $270.1M | ||
| Q2 25 | $1.0B | $252.6M | ||
| Q1 25 | $1.0B | $201.3M | ||
| Q4 24 | $1.1B | $185.5M | ||
| Q3 24 | $1.1B | $193.1M | ||
| Q2 24 | $1.1B | $177.5M | ||
| Q1 24 | $1.1B | $168.7M |
| Q4 25 | $1.4B | $2.7B | ||
| Q3 25 | $1.4B | $2.6B | ||
| Q2 25 | $1.4B | $2.6B | ||
| Q1 25 | $1.3B | $2.6B | ||
| Q4 24 | $1.4B | $2.5B | ||
| Q3 24 | $1.4B | $2.5B | ||
| Q2 24 | $1.4B | $2.5B | ||
| Q1 24 | $1.5B | $2.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $43.8M |
| Free Cash FlowOCF − Capex | $-44.6M | $41.3M |
| FCF MarginFCF / Revenue | -99.4% | 125.1% |
| Capex IntensityCapex / Revenue | 21.9% | 7.6% |
| Cash ConversionOCF / Net Profit | — | 3.53× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $69.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $43.8M | ||
| Q3 25 | $-52.6M | $30.2M | ||
| Q2 25 | $-32.4M | $-5.0M | ||
| Q1 25 | $-11.6M | $4.8M | ||
| Q4 24 | $-108.6M | $34.6M | ||
| Q3 24 | $-28.9M | $10.2M | ||
| Q2 24 | $-30.0M | $9.3M | ||
| Q1 24 | $-41.7M | $2.3M |
| Q4 25 | $-44.6M | $41.3M | ||
| Q3 25 | $-61.5M | $29.6M | ||
| Q2 25 | $-45.8M | $-5.7M | ||
| Q1 25 | $-22.2M | $4.3M | ||
| Q4 24 | $-187.0M | $32.9M | ||
| Q3 24 | $-47.4M | $10.0M | ||
| Q2 24 | $-50.1M | $9.2M | ||
| Q1 24 | $-65.8M | $2.0M |
| Q4 25 | -99.4% | 125.1% | ||
| Q3 25 | -687.0% | 87.8% | ||
| Q2 25 | -267.9% | -17.5% | ||
| Q1 25 | -524.0% | 15.5% | ||
| Q4 24 | -3702.8% | 120.0% | ||
| Q3 24 | -728.4% | 36.7% | ||
| Q2 24 | -683.8% | 32.8% | ||
| Q1 24 | -661.5% | 7.9% |
| Q4 25 | 21.9% | 7.6% | ||
| Q3 25 | 99.7% | 1.8% | ||
| Q2 25 | 78.2% | 2.3% | ||
| Q1 25 | 251.1% | 1.8% | ||
| Q4 24 | 1552.7% | 6.3% | ||
| Q3 24 | 284.6% | 1.1% | ||
| Q2 24 | 274.6% | 0.4% | ||
| Q1 24 | 242.5% | 1.0% |
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | — | -0.47× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | — | 4.83× | ||
| Q3 24 | — | 3.19× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
